Compare Roivant Sciences Ltd. Common Shares (ROIV) vs Vivmark Residential Common Shares of Beneficial Interest (VMRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roivant Sciences Ltd. Common Shares vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B), while Vivmark Residential Common Shares of Beneficial Interest trades at $61.16 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is the larger of the two by market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.68% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 1 Days and Vivmark Residential Common Shares of Beneficial Interest for 1 Days on average.
| ROIV | VMRK | |
|---|---|---|
Market Cap | $24.72B | $46.41B |
Volume | 6,279,442 | 6,584,008 |
Sector | Health | Real Estate |
52-Week High | $41.81 | $70.15 |
52-Week Low | $16.04 | $57.98 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $20.99B | $55.52B |
Dividend Yield | — | 4.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →About Vivmark Residential Common Shares of Beneficial Interest
Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →
